Skip to main content
Tag

First Indication

The average investment for a first indication launch was $13 million, with an average maximum spend of $20 million across the 12 pharma companies surveyed, which included Pfizer, Amgen, Bayer, Novartis and Eli Lilly.

Best Practices / Beth Snyder Bulik